Therapeutic monitoring of vancomycin for serious methicillin-resistant <i>Staphylococcus aureus</i> infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists

J. Rybak, Michael; Lê, Jennifer; P. Lodise, Thomas; P. Levine, Donald; S. Bradley, John; Liu, Catherine; A. Mueller, Bruce; P. Pai, Manjunath; Wong‐Beringer, Annie; C. Rotschafer, John; A. Rodvold, Keith; Maples, Holly; M. Lomaestro, Benjamin

doi:10.1093/ajhp/zxaa036

Public

Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists

Published in American Journal of Health-System Pharmacy • Mar 19, 2020

Authors:

Michael J. Rybak

Jennifer Lê

Thomas P. Lodise

Abstract

Recent clinical data on vancomycin pharmacokinetics and pharmacodynamics suggest a reevaluation of current dosing and monitoring recommendations. The previous 2009 vancomycin consensus guidelines recommend trough monitoring as a surrogate marker for the target area under the curve over 24 hours to m...

Subject

Vancomycin

Medicine

Pediatric Infectious Disease

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!